Geron Corporation (GERN) was a big mover last session with its shares rising over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has gained over 61% in the past one-month time frame.
This clinical stage biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Geron currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the broader medical sector may consider other well-placed stocks like ANI Pharmaceuticals, Inc. (ANIP), Actelion Ltd. (ALIOF) and Agenus Inc. (AGEN). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
GERON CP (GERN): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AGENUS INC (AGEN): Free Stock Analysis Report
Zacks Investment Research